5
|
Imatoh T, Yengo L, Rocheleau G, Kamimura S, Maeda S, Miyazaki M, Froguel P. ALDH2 Polymorphism rs671, but Not ADH1B Polymorphism rs1229984, Increases Risk for Hypo-HDL-Cholesterolemia in a/a Carriers Compared to the G/G Carriers. Lipids 2018; 53:797-807. [PMID: 30334266 DOI: 10.1002/lipd.12087] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2018] [Revised: 08/30/2018] [Accepted: 08/31/2018] [Indexed: 01/02/2023]
Abstract
It has been reported that polymorphisms within the gene-encoding enzymes related to alcohol metabolism are associated with levels of serum HDL-cholesterol (HDL-C) in East Asian populations. We evaluated the effects of genetic variants within the aldehyde dehydrogenase-2 (ALDH2) gene and the alcohol dehydrogenase-1B (ADH1B) gene on changes in the lipid profile in an 11-year longitudinal study. We genotyped rs1229984 within ADH1B and rs671 within ALDH2. We combined the genetic data with longitudinal clinical and biochemical data from 2002 to 2013 and designed a retrospective longitudinal study of 1436 Japanese males. There were significant negative relationships between rs671 within ALDH2 and HDL-C levels according to multiple linear regression analysis. Next, we assessed the association between the development of hypo-HDL cholesterolemia and rs1229984 within ADH1B or rs671 within ALDH2. In logistic regression analysis, rs671 A allele homozygote carriers have 2.65 times higher risk of developing hypo-HDL cholesterolemia than G allele homozygote carriers. Even after adjusting for possible confounding factors, a significant association was observed. However, no association between rs1229984 within ADH1B and the development of hypo-HDL cholesterolemia was observed. Rs671 within ALDH2 but not rs1229984 within ADH1B was associated with lower HDL-C levels in Japanese males.
Collapse
Affiliation(s)
- Takuya Imatoh
- Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, 7-45-1, Nanakuma Jonan-ku, Fukuoka, 814-0180, Japan.,Division of Medical Safety Science, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki-ku, Kanagawa, 210-0821, Japan
| | - Loic Yengo
- Université de Lille 2, CNRS, CHU Lille, Institut Pasteur de Lille, UMR 8199 - EGID, Pôle recherche, 1 place de Verdun, Lille, 59045 Cedex, France
| | - Ghislain Rocheleau
- Université de Lille 2, CNRS, CHU Lille, Institut Pasteur de Lille, UMR 8199 - EGID, Pôle recherche, 1 place de Verdun, Lille, 59045 Cedex, France
| | - Seiichiro Kamimura
- Department of Internal Medicine, Division of Preventive Medicine, Tenjin Clinic, 2-12-1, Tenjin, Chuou-ku, Fukuoka, Fukuoka, 810-0001, Japan
| | - Shiro Maeda
- Department of Advanced Genomic and Laboratory Medicine, Graduate School of Medicine, University of the Ryukyus, 207 Banchi Uehara, Nishihara-cho, Nakagami-gun, Okinawa, 9030215, Japan.,Division of Clinical Laboratory and Blood Transfusion, University of the Ryukyus Hospital, 207 Banchi Uehara, Nishihara-cho, Nakagami-gun, Okinawa, 9030215, Japan
| | - Motonobu Miyazaki
- Saitama City Institute of Health Science and Research, 7-5-12, Suzuya, Chuou-ku, Saitama, 338-0013, Japan
| | - Philippe Froguel
- Université de Lille 2, CNRS, CHU Lille, Institut Pasteur de Lille, UMR 8199 - EGID, Pôle recherche, 1 place de Verdun, Lille, 59045 Cedex, France.,Department of Genomics of Common Disease, School of Public Health, Imperial College, South Kensington Campus, London, SW7 2AZ, UK
| |
Collapse
|
11
|
Mizuno Y, Harada E, Morita S, Kinoshita K, Hayashida M, Shono M, Morikawa Y, Murohara T, Nakayama M, Yoshimura M, Yasue H. East asian variant of aldehyde dehydrogenase 2 is associated with coronary spastic angina: possible roles of reactive aldehydes and implications of alcohol flushing syndrome. Circulation 2015; 131:1665-73. [PMID: 25759460 DOI: 10.1161/circulationaha.114.013120] [Citation(s) in RCA: 64] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/03/2014] [Accepted: 03/09/2015] [Indexed: 01/27/2023]
Abstract
BACKGROUND Coronary spastic angina (CSA) is a common disease among East Asians, including Japanese. The prevalence of alcohol flushing syndrome associated with deficient activity of the variant aldehyde dehydrogenase 2 (ALDH2*2) genotype is prevalent among East Asians. We examined whether CSA is associated with the ALDH2*2 genotype in Japanese. METHODS AND RESULTS The study subjects consisted of 202 patients in whom intracoronary injection of acetylcholine was performed by angiography on suspicion of CSA (119 men and 83 women; mean age, 66.2±11.4 years). They were divided into CSA (112 patients) and control groups (90 patients). ALDH2 genotyping was performed by the direct application of the TaqMan polymerase chain reaction system on dried whole blood. Clinical and laboratory data were examined using conventional methods. The frequencies of male sex, ALDH2*2 genotype carriers, alcohol flushing syndrome, tobacco smoking, and the plasma level of uric acid were higher (P<0.001, P<0.001, P<0.001, P<0.001, and P=0.007, respectively) and the plasma high-density lipoprotein cholesterol levels were lower (P<0.001) in the CSA group than in the control group. The multivariable logistic regression analysis revealed that ALDH2*2 genotype and smoking were significantly associated with CSA (P<0.001 and P=0.024, respectively). CONCLUSIONS East Asian variant ALDH2*2 genotypes and, hence, deficient ALDH2 activity were associated with CSA in Japanese. These data support further investigation of treatment targeting aldehydes for CSA.
Collapse
Affiliation(s)
- Yuji Mizuno
- From Division of Cardiovascular Medicine, Kumamoto Kinoh Hospital, Kumamoto Aging Research Institute, Kumamoto, Japan (Y.M., E.H., S.M., M.S., H.Y.); Department of Cardiology, Nagoya University, Graduate School of Medicine, Nagoya, Japan (S.M., T.M.); School of Pharmaceutical Sciences, Mukogawa Women's University, Koshien, Nishinomiya, Japan (K.K., M.H.); Division of Cardiovascular Medicine, Nara City Hospital, Nara, Japan (Y.M.); Nakayama Cardiovascular Clinic, Amakusa, Japan (M.N.); and Division of Cardiology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan (M.Y.)
| | - Eisaku Harada
- From Division of Cardiovascular Medicine, Kumamoto Kinoh Hospital, Kumamoto Aging Research Institute, Kumamoto, Japan (Y.M., E.H., S.M., M.S., H.Y.); Department of Cardiology, Nagoya University, Graduate School of Medicine, Nagoya, Japan (S.M., T.M.); School of Pharmaceutical Sciences, Mukogawa Women's University, Koshien, Nishinomiya, Japan (K.K., M.H.); Division of Cardiovascular Medicine, Nara City Hospital, Nara, Japan (Y.M.); Nakayama Cardiovascular Clinic, Amakusa, Japan (M.N.); and Division of Cardiology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan (M.Y.)
| | - Sumio Morita
- From Division of Cardiovascular Medicine, Kumamoto Kinoh Hospital, Kumamoto Aging Research Institute, Kumamoto, Japan (Y.M., E.H., S.M., M.S., H.Y.); Department of Cardiology, Nagoya University, Graduate School of Medicine, Nagoya, Japan (S.M., T.M.); School of Pharmaceutical Sciences, Mukogawa Women's University, Koshien, Nishinomiya, Japan (K.K., M.H.); Division of Cardiovascular Medicine, Nara City Hospital, Nara, Japan (Y.M.); Nakayama Cardiovascular Clinic, Amakusa, Japan (M.N.); and Division of Cardiology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan (M.Y.)
| | - Kenji Kinoshita
- From Division of Cardiovascular Medicine, Kumamoto Kinoh Hospital, Kumamoto Aging Research Institute, Kumamoto, Japan (Y.M., E.H., S.M., M.S., H.Y.); Department of Cardiology, Nagoya University, Graduate School of Medicine, Nagoya, Japan (S.M., T.M.); School of Pharmaceutical Sciences, Mukogawa Women's University, Koshien, Nishinomiya, Japan (K.K., M.H.); Division of Cardiovascular Medicine, Nara City Hospital, Nara, Japan (Y.M.); Nakayama Cardiovascular Clinic, Amakusa, Japan (M.N.); and Division of Cardiology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan (M.Y.)
| | - Mariko Hayashida
- From Division of Cardiovascular Medicine, Kumamoto Kinoh Hospital, Kumamoto Aging Research Institute, Kumamoto, Japan (Y.M., E.H., S.M., M.S., H.Y.); Department of Cardiology, Nagoya University, Graduate School of Medicine, Nagoya, Japan (S.M., T.M.); School of Pharmaceutical Sciences, Mukogawa Women's University, Koshien, Nishinomiya, Japan (K.K., M.H.); Division of Cardiovascular Medicine, Nara City Hospital, Nara, Japan (Y.M.); Nakayama Cardiovascular Clinic, Amakusa, Japan (M.N.); and Division of Cardiology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan (M.Y.)
| | - Makoto Shono
- From Division of Cardiovascular Medicine, Kumamoto Kinoh Hospital, Kumamoto Aging Research Institute, Kumamoto, Japan (Y.M., E.H., S.M., M.S., H.Y.); Department of Cardiology, Nagoya University, Graduate School of Medicine, Nagoya, Japan (S.M., T.M.); School of Pharmaceutical Sciences, Mukogawa Women's University, Koshien, Nishinomiya, Japan (K.K., M.H.); Division of Cardiovascular Medicine, Nara City Hospital, Nara, Japan (Y.M.); Nakayama Cardiovascular Clinic, Amakusa, Japan (M.N.); and Division of Cardiology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan (M.Y.)
| | - Yoshinobu Morikawa
- From Division of Cardiovascular Medicine, Kumamoto Kinoh Hospital, Kumamoto Aging Research Institute, Kumamoto, Japan (Y.M., E.H., S.M., M.S., H.Y.); Department of Cardiology, Nagoya University, Graduate School of Medicine, Nagoya, Japan (S.M., T.M.); School of Pharmaceutical Sciences, Mukogawa Women's University, Koshien, Nishinomiya, Japan (K.K., M.H.); Division of Cardiovascular Medicine, Nara City Hospital, Nara, Japan (Y.M.); Nakayama Cardiovascular Clinic, Amakusa, Japan (M.N.); and Division of Cardiology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan (M.Y.)
| | - Toyoaki Murohara
- From Division of Cardiovascular Medicine, Kumamoto Kinoh Hospital, Kumamoto Aging Research Institute, Kumamoto, Japan (Y.M., E.H., S.M., M.S., H.Y.); Department of Cardiology, Nagoya University, Graduate School of Medicine, Nagoya, Japan (S.M., T.M.); School of Pharmaceutical Sciences, Mukogawa Women's University, Koshien, Nishinomiya, Japan (K.K., M.H.); Division of Cardiovascular Medicine, Nara City Hospital, Nara, Japan (Y.M.); Nakayama Cardiovascular Clinic, Amakusa, Japan (M.N.); and Division of Cardiology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan (M.Y.)
| | - Masafumi Nakayama
- From Division of Cardiovascular Medicine, Kumamoto Kinoh Hospital, Kumamoto Aging Research Institute, Kumamoto, Japan (Y.M., E.H., S.M., M.S., H.Y.); Department of Cardiology, Nagoya University, Graduate School of Medicine, Nagoya, Japan (S.M., T.M.); School of Pharmaceutical Sciences, Mukogawa Women's University, Koshien, Nishinomiya, Japan (K.K., M.H.); Division of Cardiovascular Medicine, Nara City Hospital, Nara, Japan (Y.M.); Nakayama Cardiovascular Clinic, Amakusa, Japan (M.N.); and Division of Cardiology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan (M.Y.)
| | - Michihiro Yoshimura
- From Division of Cardiovascular Medicine, Kumamoto Kinoh Hospital, Kumamoto Aging Research Institute, Kumamoto, Japan (Y.M., E.H., S.M., M.S., H.Y.); Department of Cardiology, Nagoya University, Graduate School of Medicine, Nagoya, Japan (S.M., T.M.); School of Pharmaceutical Sciences, Mukogawa Women's University, Koshien, Nishinomiya, Japan (K.K., M.H.); Division of Cardiovascular Medicine, Nara City Hospital, Nara, Japan (Y.M.); Nakayama Cardiovascular Clinic, Amakusa, Japan (M.N.); and Division of Cardiology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan (M.Y.)
| | - Hirofumi Yasue
- From Division of Cardiovascular Medicine, Kumamoto Kinoh Hospital, Kumamoto Aging Research Institute, Kumamoto, Japan (Y.M., E.H., S.M., M.S., H.Y.); Department of Cardiology, Nagoya University, Graduate School of Medicine, Nagoya, Japan (S.M., T.M.); School of Pharmaceutical Sciences, Mukogawa Women's University, Koshien, Nishinomiya, Japan (K.K., M.H.); Division of Cardiovascular Medicine, Nara City Hospital, Nara, Japan (Y.M.); Nakayama Cardiovascular Clinic, Amakusa, Japan (M.N.); and Division of Cardiology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan (M.Y.).
| |
Collapse
|